Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)
This study has been completed.
Study NCT00194922   Information provided by Weill Medical College of Cornell University

First Received on September 12, 2005.   Last Updated on April 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Irritable Bowel Syndrome (IBS)
Additional conditions recognized in this trial
Irritable Bowel Syndrome
More general conditions related to this trial
Colonic Diseases
Colonic Diseases, Functional
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Interventions listed in this trial
E. Coli Strain M17 Probiotic
Sponsors listed in this trial
Weill Medical College of Cornell University
BioBalance Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services